Celregen Obtains News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Celregen obtains. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Celregen Obtains Today - Breaking & Trending Today

Cellusion and Celregen, a member of Fosun Pharma, Enter into Exclusive License Agreement of CLS001 f

Celregen Obtains the Exclusive Rights to Develop, Manufacturing and Commercialize CLS001 in Greater China Region; Cellusion Retains Other Regional Rights.The Deal is Worth up to over $100 Million, including Upfront, Development and Sales Milestone Payments, and Tiered Royalties.TOKYO & HANGZHOU, China & SHANGHAI (B. ....

United States , Hong Kong , Wen Deyong , Joji Hayashida , Jialei Ma , Shin Hatou , Fosun Pharma , Cui Zhiping , Keio University School Of Medicine , Sinopharm Co Ltd , Shanghai Fosun Pharmaceutical Group Co Ltd , Fosun Health Capital , Drug Fund , Hangzhou Celregen Therapeutics Ltd , Icellusion Inc , Drug Fund Of Fosun Health Capital , Fosun New Drug Fund , Keio University Hospital , Department Of Ophthalmology , Celregen Obtains , Exclusive Rights , Greater China Region , Sales Milestone Payments , Corneal Endothelial Cell Substitute , Hangzhou Celregen Therapeutics , Shanghai Fosun Pharmaceutical ,